NPI Details
DR. Vikram Sengupta, MD is an internal medicine in Manhasset, NY with 15 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Vikram Sengupta, MD NPI is 1740568153. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: YALE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2011
The provider's business location address is:
333 E SHORE RD STE 201
MANHASSET, NY
ZIP 11030-900
Phone: (212) 803-3339
The NPI 1740568153 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
- Injection, teprotumumab-trbw, 10 mg (HCPCS:J3241)
- Injection, vedolizumab, 1 mg (HCPCS:J3380)
- Injection, inclisiran, 1 mg (HCPCS:J1306)
- Ustekinumab, for intravenous injection, 1 mg (HCPCS:J3358)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
- Unclassified drugs (HCPCS:J3490)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- Injection of drug or substance into vein (HCPCS:96374)
The enumeration date for this NPI number is 8/2/2011 and was last updated on 1/16/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 266344 | MASSACHUSETTS | Yes |
| 2 | 207R00000X | Internal Medicine | | 276713 | NEW YORK | No |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 04072482 | MEDICAID | NEW YORK | |
